ES2241571T3 - N-oxidos de fenantrinida con actividad inhividora de pde-iv. - Google Patents

N-oxidos de fenantrinida con actividad inhividora de pde-iv.

Info

Publication number
ES2241571T3
ES2241571T3 ES00901539T ES00901539T ES2241571T3 ES 2241571 T3 ES2241571 T3 ES 2241571T3 ES 00901539 T ES00901539 T ES 00901539T ES 00901539 T ES00901539 T ES 00901539T ES 2241571 T3 ES2241571 T3 ES 2241571T3
Authority
ES
Spain
Prior art keywords
compounds
alkyl
alkoxy
hydrogen
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES00901539T
Other languages
English (en)
Spanish (es)
Inventor
Dieter Flockerzi
Hermann Amschler
Armin Hatzelmann
Daniela Bundschuh
Rolf Beume
Hildegard Boss
Hans-Peter Kley
Beate Schmidt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda GmbH
Original Assignee
Altana Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma AG filed Critical Altana Pharma AG
Application granted granted Critical
Publication of ES2241571T3 publication Critical patent/ES2241571T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Junction Field-Effect Transistors (AREA)
  • Pyridine Compounds (AREA)
ES00901539T 1999-01-15 2000-01-13 N-oxidos de fenantrinida con actividad inhividora de pde-iv. Expired - Lifetime ES2241571T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99100693 1999-01-15
EP99100693 1999-01-15

Publications (1)

Publication Number Publication Date
ES2241571T3 true ES2241571T3 (es) 2005-11-01

Family

ID=8237350

Family Applications (1)

Application Number Title Priority Date Filing Date
ES00901539T Expired - Lifetime ES2241571T3 (es) 1999-01-15 2000-01-13 N-oxidos de fenantrinida con actividad inhividora de pde-iv.

Country Status (12)

Country Link
US (1) US6534519B1 (https=)
EP (1) EP1147103B1 (https=)
JP (1) JP2003502278A (https=)
AT (1) ATE294793T1 (https=)
AU (1) AU2290000A (https=)
CA (1) CA2359449A1 (https=)
DE (1) DE60019894T2 (https=)
DK (1) DK1147103T3 (https=)
ES (1) ES2241571T3 (https=)
PT (1) PT1147103E (https=)
SI (1) SI1147103T1 (https=)
WO (1) WO2000042034A1 (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1650193A3 (en) * 1999-01-15 2006-10-04 ALTANA Pharma AG 6-Phenylphenanthridines with PDE-IV inhibiting activity
CA2396026A1 (en) 2000-01-11 2001-07-19 Byk Gulden Lomberg Chemische Fabrik Gmbh Phenanthridine-n-oxides
PT1303506E (pt) 2000-07-14 2005-06-30 Altana Pharma Ag 6-heteroarilfenantridinas
CA2495827C (en) * 2002-08-29 2012-05-08 Altana Pharma Ag 2-hydroxy-6-phenylphenanthridines as pde-4 inhibitors
ES2281658T3 (es) 2002-08-29 2007-10-01 Nycomed Gmbh 3-hidroxi-6-fenilfenantridinas como inhibidores de pde-4.
EP1658270A1 (en) * 2003-07-31 2006-05-24 ALTANA Pharma AG Novel 6-phenylphenantridines
CA2533636A1 (en) * 2003-07-31 2005-02-10 Altana Pharma Ag Novel 6-phenylphenanthridines
US20050187278A1 (en) * 2003-08-28 2005-08-25 Pharmacia Corporation Treatment or prevention of vascular disorders with Cox-2 inhibitors in combination with cyclic AMP-specific phosphodiesterase inhibitors
WO2005023253A1 (en) * 2003-09-05 2005-03-17 Altana Pharma Ag Use of pde4 inhibitors for the treatment of diabetes mellitus
AU2005212857B2 (en) 2004-02-18 2011-04-28 Takeda Gmbh Novel guanidinyl-substituted hydroxy-6-phenylphenenthridines as effective phosphodiesterase (PDE) 4 inhibitors
AR049419A1 (es) * 2004-03-03 2006-08-02 Altana Pharma Ag Hidroxi-6-fenilfenantridinas sustituidas con heterociclilo
CN104803974A (zh) 2004-03-03 2015-07-29 塔科达有限责任公司 新的羟基-6-杂芳基菲啶及其作为pde4抑制剂的用途
JP2007527901A (ja) * 2004-03-10 2007-10-04 アルタナ　ファルマ　アクチエンゲゼルシャフト アミド置換された新規のヒドロキシ−６−フェニルフェナントリジン及びｐｄｅ４インヒビターとしてのそれらの使用
ES2337083T3 (es) 2005-03-02 2010-04-20 Nycomed Gmbh (2r,4ar,10br)-6-(2,6-dimetoxipiridin-3-il)-9-exoti-8-metoxi-1,2,3,4,4a,10b-hexahidrofenantridin-2-ol, sal de hc1.
AU2006222060B2 (en) 2005-03-08 2011-09-01 Takeda Gmbh Roflumilast for the treatment of diabetes mellitus
MX2010003155A (es) 2007-10-04 2010-04-01 Hoffmann La Roche Derivados de ciclopropil aril amida y uso de los mismos.
WO2013106547A1 (en) 2012-01-10 2013-07-18 President And Fellows Of Harvard College Beta-cell replication promoting compounds and methods of their use

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5455252A (en) * 1993-03-31 1995-10-03 Syntex (U.S.A.) Inc. Optionally substituted 6,8-quinolines
US5475003A (en) * 1994-03-03 1995-12-12 Syntex (U.S.A.) Inc. 8-phenylcyclopentenoquinoline and 8-phenylcyclohexenoquinoline derivatives
CA2143143A1 (en) * 1994-03-08 1995-09-09 Toshihiko Tanaka 3-phenylpyrrolidine derivatives
US5466697A (en) * 1994-07-13 1995-11-14 Syntex (U.S.A.) Inc. 8-phenyl-1,6-naphthyridin-5-ones
UA48216C2 (uk) 1996-01-31 2002-08-15 Бік Гулден Ломберг Кеміше Фабрік Гмбх Фенантридини та лікарський засіб для лікування захворювань дихальних шляхів
US6127378A (en) 1996-03-26 2000-10-03 Byk Gulden Lomberg Chemische Fabrik Gmbh Phenanthridines substituted in the 6 position
WO1997035854A1 (de) * 1996-03-26 1997-10-02 Byk Gulden Lomberg Chemische Fabrik Gmbh Neue in 6-position substituierte phenanthridine
GB9622386D0 (en) 1996-10-28 1997-01-08 Sandoz Ltd Organic compounds
EE03829B1 (et) 1996-11-11 2002-08-15 Byk Gulden Lomberg Chemische Fabrik Gmbh Bensonaftüridiinid, nende kasutamine bronhiaalravimi valmistamiseks ning neid sisaldav ravim
GB9626643D0 (en) 1996-12-21 1997-02-12 Astra Pharma Prod Compounds
JP2001514640A (ja) 1997-03-07 2001-09-11 ビイク グルデン ロンベルク ヒエーミツシエ フアブリーク ゲゼルシヤフト ミツト ベシユレンクテル ハフツング 新規のテトラゾール
CA2291153A1 (en) 1997-06-03 1998-12-10 Byk Gulden Lomberg Chemische Fabrik Gmbh Benzonaphthyridine
DE69822162T2 (de) 1997-07-25 2005-01-27 Altana Pharma Ag Neue tetrazolderivate
AU5970199A (en) 1998-08-31 2000-03-21 Byk Gulden Lomberg Chemische Fabrik Gmbh Benzonaphthyridine-n-oxides comprising a pde3 and pde4 inhibiting activity

Also Published As

Publication number Publication date
DK1147103T3 (da) 2005-08-29
JP2003502278A (ja) 2003-01-21
DE60019894D1 (de) 2005-06-09
DE60019894T2 (de) 2006-01-12
CA2359449A1 (en) 2000-07-20
EP1147103B1 (en) 2005-05-04
WO2000042034A1 (en) 2000-07-20
PT1147103E (pt) 2005-08-31
SI1147103T1 (en) 2005-10-31
ATE294793T1 (de) 2005-05-15
EP1147103A1 (en) 2001-10-24
US6534519B1 (en) 2003-03-18
AU2290000A (en) 2000-08-01

Similar Documents

Publication Publication Date Title
ES2217575T3 (es) Nuevos derivados de tetrazol.
ES2241571T3 (es) N-oxidos de fenantrinida con actividad inhividora de pde-iv.
CA2245142C (en) New phenanthridines
JP4653314B2 (ja) Ｐｄｅ−ｉｖ阻害作用を有するフェニルフェナントリジン
CA2495597A1 (en) Novel phenanthridines
CA2330738A1 (en) Novel n-oxides of benzonaphthyridines
ES2224745T3 (es) N-oxidos de benzonaftiridina con actividad inhibidora de pde3 y pde4.
ES2206909T3 (es) Derivados de tetrazol.
ES2255483T3 (es) 6-arilfenantridinas con actividad inhibidora de pde-iv.
US6534518B1 (en) Polysubstituted 6-phenylphenanthridines with PDE-IV inhibiting activity
EP1000034B1 (en) Substituted 6-alkylphenanthridines
ES2242594T3 (es) N-oxidos de fenantridinas con una acitvidad inhidora de pde-iv.
WO2002005616A1 (en) Novel 6-phenylphenanthridines
ES2236288T3 (es) 6-heteroarilfenantridinas.
AU782908B2 (en) Phenanthridine-N-oxides
AU758194B2 (en) Novel benzimidazoles and benzoxazoles
IL125286A (en) Phenanthridine compounds and medicaments containing the same
WO2002006239A1 (en) Phenanthridine n-oxides